Examkin

Question

Difficulty: MediumMenstrual Cycle Abnormalities and Contraception

A 24-year-old nulligravid woman presents to the office reporting that she has not had a menstrual period for the past 8 months. Menarche occurred at age 13, and her menses were previously regular, occurring every 28 to 30 days and lasting 5 days. She reports no headaches, visual changes, nipple discharge, heat intolerance, or weight changes. She is not taking any medications and does not use illicit substances. Vital signs are within normal limits. Her BMI is 22 kg/m 2^2. Physical examination reveals a normal thyroid gland, normal breast development without galactorrhea, and a normal pelvic examination with no clitoromegaly or virilization.

Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's secondary amenorrhea, from the absolute first step to subsequent evaluations.

  1. 1Perform a urine beta-hCG pregnancy test
  2. 2Measure serum thyroid-stimulating hormone (TSH) and prolactin levels
  3. 3Administer an oral progestin challenge test
  4. 4Measure serum follicle-stimulating hormone (FSH) levels

Answer

The correct sequential order for the evaluation of secondary amenorrhea is: 1) Perform a urine beta-hCG pregnancy test, 2) Measure serum TSH and prolactin levels, 3) Administer an oral progestin challenge test, and 4) Measure serum FSH levels.
The evaluation of secondary amenorrhea follows a strictly tiered diagnostic algorithm. First, pregnancy must be ruled out with a beta-hCG test. Second, TSH and prolactin are measured to evaluate for common, treatable endocrine conditions (hypothyroidism, hyperprolactinemia). Third, a progestin challenge test evaluates the functional integrity of the outflow tract and the presence of endogenous estrogen (if positive, it implies anovulation, such as in PCOS). Finally, if the progestin challenge is negative (no withdrawal bleeding), serum FSH is measured to differentiate between a primary ovarian defect (elevated FSH) and a central hypothalamic/pituitary defect (low/normal FSH).

Step-by-Step Solution

1
Exclude pregnancy.
Perform a beta-hCG test.
Pregnancy is the leading cause of secondary amenorrhea and must be confidently excluded before further costly or potentially teratogenic steps are taken.
2
Evaluate for common secondary endocrine causes.
Measure serum TSH and prolactin.
Thyroid dysfunction (hypothyroidism) and hyperprolactinemia can directly cause anovulation and amenorrhea. Identifying these directs immediate, specific medical therapy (e.g., levothyroxine or dopamine agonists).
3
Assess estrogen status and outflow tract patency.
Administer a progestin challenge test.
A withdrawal bleed indicates the patient has an intact outflow tract and is producing enough endogenous estrogen to proliferate the endometrium (typical of anovulation/PCOS). No bleed indicates hypoestrogenism or an outflow tract obstruction.
4
Localize the defect if the progestin challenge is negative.
Measure serum FSH levels.
If there is no withdrawal bleed, distinguishing between an ovarian etiology (high FSH due to lack of negative feedback) and a central hypothalamic-pituitary etiology (low/normal FSH) is necessary.

Key Concept

The step-wise diagnostic algorithm for secondary amenorrhea prioritizes ruling out pregnancy, followed by identifying common endocrine disorders, assessing estrogen status, and localizing the HPO axis defect.
Rate this question

Topics

Menstrual Cycle Abnormalities and Contraception

More questions from this topic